| 영문 | plasma | 한글 | 혈장 |
|---|---|---|---|
| 설명 | 혈액이나 림프액의 액체 부분을 말하는데, 주로 혈액에서 고형성분(혈구세포)을 제외한 액체 부분을 의미한다. 여기에는 단백성분(면역현상을 유발하는 항체를 포함함), 영양성분(각 세포에 영양분을 공급함), 그리고 혈액응고 성분(상처가 났을 때 출혈이 멎을 수 있도록 함) 등이 포함된다. |
||
| 영문 | plasma membrane | 한글 | 형질막 |
|---|---|---|---|
| 설명 | 원형질 표면을 덮는 엷은막. 두께는 5~25μm이다. 광학현미경으로는 관찰할 수 없지만 전자현미경으로 관찰이 가능하다. 원형질막의 분자구조는 레시틴이나 콜레스테롤 등의 표면 활성물질 분자가 2분자층으로 그 표면에 배열되며, 이것을 각 1분자층의 단백질 분자가 양쪽에서 샌드위치한 단위막 구조이다. 전자현미경적으로 이 단위는 암-명-암의 3층(각 약 20nm)으로 구별된다. 원형질의 투과성에 중요한 구실을 하며, 생리상태가 변하면 그 투과성도 신속히 변한다. 또, 손상이 되면 쉽게 새로 형성된다. |
||
| PCDC | plasma clot diffusion chamber |
|---|---|
| FENa, FeNa | Fractional Excretion of Sodium ; Volume의 개념을 제거하여 좀 더 정확한 신장의 농축 능력을 평가, &n... |
| TPC | thromboplastic plasma component; thyroid papillary carcinoma; total patient care; total plasma catec... |
| BLT | bleeding time; blood-clot lysis time; blood test |
| CLT | Certified Laboratory Technician; chronic lymphocytic thyroiditis; Clinical Laboratory Technician; cl... |
| ECLT | Euglobulin Clot Lysis time |
|---|---|
| PRP | 1--Platelet-rich plasma |
| APC | Argon Plasma Coagulation |
| BPA | Bovine plasma albumin |
| D/P | Dialysate to plasma |
| agonal clot | Intravascular thrombosis ascribed to the process of dying. (05 Mar 2000) |
|---|---|
| antemortem clot | A blood clot, found at autopsy, formed in any of the heart cavities or the great vessels before death. (05 Mar 2000) |
| blood clot | <haematology> The conversion of blood from a liquid form to solid through the process of coagulation. A thrombus is a clot which forms inside of a blood vessel. If that clot moves inside the vessel it is referred to as an embolus (embolism). The presence of atherosclerotic plaque lining blood vessel walls is a significant stimulus for clot formation. (27 Sep 1997) |
| passive clot | A clot formed in an aneurysmal sac consequent to the cessation or slowing of circulation through the aneurysm. (05 Mar 2000) |
| medication, clot-dissolving | Drugs used to dissolve blood clots. Agents such as plasminogen-activator (t-pa) and streptokinase that are effective in dissolving clots and re-opening arteries. Used, for example, in the treatment of heart attacks. Clot-dissolvers are also called thrombolytic agents. (12 Dec 1998) |
| chicken fat clot | Clot formed in vitro or postmortem from leukocytes and plasma of sedimented blood. (05 Mar 2000) |
| clot | 1. To coagulate, said especially of blood. 2. A soft, nonrigid, insoluble mass formed when a liquid (e.g., blood or lymph) gels. Origin: O.E. Klott, lump (05 Mar 2000) |
| clot-dissolving medications | Agents such as plasminogen-activator (t-PA) and streptokinase that are effective in dissolving clots and re-opening arteries. Used, for example, in the treatment of heart attacks. Also called thrombolytic agents. (12 Dec 1998) |
| clot retraction | Retraction of a clot resulting from contraction of platelet pseudopods attached to fibrin strands that is dependent on the contractile protein thrombosthenin. Used as a measure of platelet function. (12 Dec 1998) |
| clot retraction time | The time required for a blood clot to separate from the tube wall and express serum, usually completed in 18 to 24 hours, but retarded or absent in persons with thrombocytopenic purpura. (05 Mar 2000) |
| mucin clot test | A test that reflects the polymerization of synovial fluid hyaluronate; a few drops of synovial fluid added to acetic acid form a clot; poor clot formation occurs in a variety of inflammatory conditions including septic arthritis, gouty arthritis, and rheumatoid arthritis. Synonym: Ropes test. (05 Mar 2000) |
| postmortem clot | A clot formed in the heart or great vessels after death. (05 Mar 2000) |
| currant jelly clot | A jelly-like mass of red blood cells and fibrin formed by the in vitro or postmortem clotting of whole or sedimented blood. (05 Mar 2000) |
| Schede's clot | Filling of the defect in bone, after removal of a sequestrum or scraping away carious material, by allowing the cavity to fill with blood which may become organised (Schede's clot). (05 Mar 2000) |
| euglobulin clot lysis time | A measure of the ability of plasminogen activators and plasmin to lyse a clot; normally, clot lysis is determined by the balance of factors which activate fibrinolysis (plasminogen activators and plasmin) and those which inhibit lysis; in certain conditions (e.g., carcinoma or hepatic insufficiency) activating factors predominate and can be measured by noting the time it takes the euglobulin fraction of plasma (excluding inhibitors of fibrinolysis) to clot. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|